Literature DB >> 20197353

Peroperative fiducial placement for postoperative stereotactic Cyberknife radiosurgery.

Daniel Pop1, Nicolas Venissac, Pierre-Yves Bondiau, Jérôme Mouroux.   

Abstract

Radiotherapy is often the treatment used for inoperable early-stage lung cancer as well as pulmonary metastases. In the last decade, efforts were done to increase local control with high-dose radiation without excessive collateral damage. Initially used for cranial lesions, stereotactic radiosurgery enlarged extracranial indications; the Cyberknife radiosurgery system needs metal (gold) markers for image guidance. For lung tumours, fiducials are inserted computed tomography (CT)-guided or bronchoscopy-guided. We describe four patients where fiducial placement was done during surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20197353     DOI: 10.1510/icvts.2009.227348

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

Review 1.  Fiducial marker placement for stereotactic body radiation therapy via convex probe endobronchial ultrasound: a case series and review of literature.

Authors:  Benjamin J Seides; John P Egan; Kim D French; Kevin L Kovitz; Neeraj R Desai
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Development of a Margin Determination Framework for Tumor-Tracking Radiation Therapy With Intraoperatively Implanted Fiducial Markers.

Authors:  Jihun Kim; Min Cheol Han; Jee Suk Chang; Chae-Seon Hong; Kyung Hwan Kim; Hwa Kyung Byun; Ryeong Hwang Park; Woong Sub Koom; Seong Yong Park; Jin Sung Kim
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

3.  Performance Evaluation of Deformable Image Registration Algorithms Using Computed Tomography of Multiple Lung Metastases.

Authors:  Min Cheol Han; Jihun Kim; Chae-Seon Hong; Kyung Hwan Chang; Su Chul Han; Kwangwoo Park; Dong Wook Kim; Hojin Kim; Jee Suk Chang; Jina Kim; Sunsuk Kye; Ryeong Hwang Park; Yoonsun Chung; Jin Sung Kim
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.